EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Continuous Glucose Monitoring Metrics in High-Risk Pregnant Women with Type 2 Diabetes

Anna McLean iD, Elizabeth Barr, Georgina Tabuai, Helen R Murphy, Louise Maple-Brown

Diabetes Technology & Therapeutics · 2023

DOI: 10.1089/dia.2023.0300 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Diabetes Technology & Therapeutics, 2023. Verfasst von Anna McLean und 4 weiteren Autor:innen. Beteiligte Einrichtung: Wellbeing and Preventable Chronic Disease Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Pregnancy in Diabetics, Hypoglycemia. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To describe glucose metrics in a high-risk population of women with type 2 diabetes (T2DM) in pregnancy and to explore the associations with neonatal outcomes. Research Design and Methods: Prospective observational study of 57 women. Continuous glucose monitoring (CGM) trajectories were determined from metrics collected in early and late gestation using the first and last two (mean 16 and 35) weeks of Freestyle Libre data. Logistic regression was used to examine associations of CGM metrics with neonatal hypoglycemia (glucose 90th percentile for gestational age and sex). Pregnancy-specific target glucose range was 3.5–7.8 mmol/L (63–140 mg/dL).

Results

Forty-one women used CGM for 15 weeks (mean age 33 years, 73% Aboriginal or Torres Strait Islander, 32% living remotely). There was limited change in average metrics from early to late pregnancy. For the subgroup with sensor use >50% ( n = 29), mean time in range (TIR) increased by 9%, time above range reduced by 12%, average glucose reduced by 1 mmol/L, and time below range increased by 3%. Neonatal hypoglycemia was associated with most CGM metrics, HbA1c and CGM targets, particularly those from late pregnancy. LGA was associated with hyperglycemic metrics from early pregnancy. Each 1% increase TIR was associated with a 4%–5% reduction in risk of neonatal complications.

Conclusion

In this high-risk group of women with T2DM, CGM metrics only improved during pregnancy in those with greater sensor use and were associated with LGA in early pregnancy and neonatal hypoglycemia throughout. Culturally appropriate health care strategies are critical for successful use of CGM technology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1Pregnancy in DiabeticsHypoglycemiaInfant, Newborn, DiseasesInfant, NewbornPregnancyFemaleHumansAdultBlood GlucosePregnant PeopleBlood Glucose Self-Monitoring

Stichwörter der Autor:innen

Aboriginal and Torres Strait IslanderContinuous glucose monitoringFlash glucose monitoringGlucose metricsIndigenousPregnancyType 2 diabetes

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Wellbeing and Preventable Chronic Disease Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia.
  • Endocrinology Department, Cairns Hospital, Cairns, Australia.
  • Norwich Medical School, University of East Anglia, Norwich, United Kingdom.
  • Endocrinology Department, Royal Darwin Hospital, Darwin, Australia.

ORCID-Profile: Anna McLean

Zitieren

APA

McLean, A., Barr, E., Tabuai, G., Murphy, H. R., & Maple-Brown, L. (2023). Continuous Glucose Monitoring Metrics in High-Risk Pregnant Women with Type 2 Diabetes. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2023.0300

Vancouver

McLean A, Barr E, Tabuai G, Murphy HR, Maple-Brown L. Continuous Glucose Monitoring Metrics in High-Risk Pregnant Women with Type 2 Diabetes. Diabetes Technology & Therapeutics. 2023. doi:10.1089/dia.2023.0300

BibTeX
@article{McLean2023,
  author = {McLean, Anna and Barr, Elizabeth and Tabuai, Georgina and Murphy, Helen R and Maple-Brown, Louise},
  title = {Continuous Glucose Monitoring Metrics in High-Risk Pregnant Women with Type 2 Diabetes},
  journal = {Diabetes Technology & Therapeutics},
  year = {2023},
  doi = {10.1089/dia.2023.0300}
}
Kostenlos starten →